dioscin has been researched along with ganciclovir in 1 studies
| Studies (dioscin) | Trials (dioscin) | Recent Studies (post-2010) (dioscin) | Studies (ganciclovir) | Trials (ganciclovir) | Recent Studies (post-2010) (ganciclovir) |
|---|---|---|---|---|---|
| 250 | 0 | 200 | 6,720 | 552 | 1,702 |
| Protein | Taxonomy | dioscin (IC50) | ganciclovir (IC50) |
|---|---|---|---|
| Transitional endoplasmic reticulum ATPase | Homo sapiens (human) | 1.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, B; Li, B; Liu, X; Tan, Y; Wu, Y; Xiao, J; Zhang, G | 1 |
1 other study(ies) available for dioscin and ganciclovir
| Article | Year |
|---|---|
Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.
Topics: Animals; Antiviral Agents; Bystander Effect; Cell Communication; Cell Survival; Connexin 26; Connexin 43; Connexins; Diosgenin; Disease Models, Animal; Drug Synergism; Ganciclovir; Genes, Transgenic, Suicide; Genetic Therapy; Melanoma, Experimental; Mice; Mutation; Simplexvirus; Thymidine Kinase; Tumor Cells, Cultured | 2017 |